4132 Share Price Performance
NT$11.70
-6.05 (-34.08%)
Price NT$11.70
Share PriceNT$11.70
Golden Biotechnology Corporation Stock Price
- 0 Narratives written by author
- 0 Comments on narratives written by author
- 0 Fair Values set on narratives written by author
4132 Community Narratives
There are no narratives available yet.
Recent 4132 News & Updates
Golden Biotechnology Corporation Key Details
Last Reported Earnings
Jun 30, 2025
Next Reporting Earnings
n/a
- Earnings per share (EPS)
- -1.94
- Gross Margin
- -25.10%
- Net Profit Margin
- -706.41%
- Debt/Equity Ratio
- 148.4%
Golden Biotechnology Corporation Competitors
Snowflake Analysis
About 4132
- Founded
- 2002
- Employees
- n/a
- CEO
- WebsiteView website
Golden Biotechnology Corporation operates as a drug discovery and healthy food supplement manufacturing company in Taiwan, the United States, Japan, China, Korea, and Singapore. Its products include Liverty that is used for liver health support and fatigue; Rasle, an auto-immune adjuvant therapy; ZSAINO, a nourishment product for recovery from illness and for health improvement; and UMOOZE, a herbal formula for optimal health in males. The company also provides Antroquinonol, an anticancer molecule for the treatment of pancreatic cancer, acute myeloid leukemia, and hepatocellular carcinoma, as well as hypercholesterolemia and hyperlipidemia. The company was founded in 2002 and is headquartered in New Taipei City, Taiwan.
Market Insight
Rare earths may be a sliver of the global metals market, but they punch far above their weight. These obscure elements are the invisible wiring of modern life.
Continue reading
Taiwanese Market Performance
- 7 Days: 5.0%
- 3 Months: 20.1%
- 1 Year: 18.3%
- Year to Date: 18.0%
Over the last 7 days, the market has risen 5.0%, driven by gains of 7.3% in the Information Technology sector. In the last year, the market has climbed 18%. Earnings are forecast to grow by 18% annually. Market details ›